Company Overview

Prosolia, Inc. was established in 2003 to commercialize technology arising from the laboratory of Dr. Graham Cooks, Aston Laboratories of Mass Spectrometry at Purdue University, West Lafayette, Indiana. Dr. Cooks and his research team have been innovators in the field of Mass Spectrometry for many years and in recent years have made a series of inventions while working on projects financially supported by The Indiana Proteomics Consortium (‘dba Inproteo”).

Inproteo was established in 2001 by Eli Lilly, Indiana University, and Purdue University in order to commercialize technologies, resident within these institutions, which were deemed to be capable of satisfying unmet needs in the mass spectrometer marketplace, but which required additional focus in order for them to reach their full commercial potential.

Prosolia’s mission is to develop and market revolutionary analytical and preparative chemistry tools that will enhance and expand the use of mass spectrometers.

Prosolia’s technology will lead to the commercialization of a series of revolutionary analytical and preparative tools that will greatly expand the utility of mass spectrometers beyond their current limitations. This will be the case generally across the mass spectrometer market through the introduction of the Omni Spray™ ion sources, and especially in the pharmaceutical and proteomics markets, through the introduction of the ESSI sources and the preparative mass spectrometers with ion soft-landing.

Prosolia’s products will transform the way mass spectrometers are used, the way biological research and testing is conducted, and will also change the research community’s expectations regarding the purity attainable for bio-polymeric materials.

Indeed, Prosolia’s mass spectrometer enhancements will “unlock the power of mass spectrometry”, allowing procedures to be routinely performed, which heretofore were very difficult if not impossible.